DIHYDROISOCHINOLINYLDERIVATE

European patent · EP4263522 · In force

Register entry

Publication number
EP4263522
Application number
EP21840512
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 16, 2021
Published
Oct 25, 2023
Granted
Oct 2, 2024
Protection ends at the latest
Dec 15, 2041
Next annual fee due
Dec 31, 2026
IPC classes
C07D 401/14 (2006.01)
A61K 31/454 (2006.01)
A61P 25/00 (2006.01)
Priority
EP 20215251 18.12.2020
PCT application
PCT/EP2021/086131 16.12.2021
PCT publication
WO2022/129303 23.06.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Aug 13, 2025

    Change

    Published in Swissreg on 13.08.2025

  3. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  4. Oct 3, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Parties

Holder

UCB Biopharma SRL

60, Allée de la Recherche, 1070 Brussels, BE

Inventor

HALL, Adrian

1070 Brussels, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.